Melquin 3
Loading...Melquin 3 Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
1. Hydroquinone is a skin bleaching agent which may produce undesired effects if not used as directed. The physician should be familiar with the contents of this insert before prescribing or dispensing this medication.
2. To evaluate possible susceptibility to irritation or sensitivity, each patient should begin by applying the medication to a small portion of unbroken skin at or near the pigmented area over a period of several days. Minor redness is not necessarily a contraindication, but treatment should be discontinued if itching, excessive inflammation or vesicle formation occurs. Use of MELQUIN-3® TOPICAL SOLUTION in paranasal and infraorbital areas increases the chance of irritations (See ADVERSE REACTIONS). If no improvement is seen after two months of treatment, use of this product should be discontinued.
3. There are no sunblocking or sunscreening agents in MELQUIN-3® TOPICAL SOLUTION. Sun exposure should be minimized by using a sunscreen agent, or protective clothing to cover bleached skin in order to prevent repigmentation from occuring. For daytime treatment use NUQUIN HP 4% CREAM, NUQUIN HP 4% GEL or MELPAQUE HP 4% CREAM.
4. Keep this and all other medications out of reach of children. In case of accidental ingestion, call a physician or a poison control center immediately.
5. Avoid contact with eyes. In case of accidental contact, patient should rinse eyes thoroughly with water and contact physician. A bitter taste and anesthetic effect may occur if applied to the lips.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
MELQUIN-3® TOPICAL SOLUTION is indicated for the temporary bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines and other undesired areas of melanin hyperpigmentation.
History
There is currently no drug history available for this drug.
Other Information
Each mL of MELQUIN-3® TOPICAL SOLUTION contains ACTIVE: Hydroquinone 3.0% (30 mg) INACTIVES: SD Alcohol 40B (45% by volume), Purified Water, Isopropyl Alcohol(4% by volume), Propylene Glycol, Laureth-4, Hydroxyethyl Cellulose and Ascorbic Acid.
Hydroquinone is 1, 4-Benzenediol, with a chemical formula of C6H6O2 and a molecular weight of 110.11. The structural formula is:
C6H6O2
Sources
Melquin 3 Manufacturers
-
Stratus Pharmaceuticals
![Melquin 3 (Hydroquinone) Liquid [Stratus Pharmaceuticals]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Melquin 3 | Stratus Pharmaceuticals
MELQUIN-3® TOPICAL SOLUTION should be applied to affected areas twice daily, in the morning and before bedtime, or as directed by a physician. During the day, an effective broad spectrum sunscreen should be used and unnecessary solar exposure avoided. There is no recommended dosage for children under 12 years of age except under the advice and supervision of a physician. Keep container tightly closed. NOTE: Slight darkening of MELQUIN-3® TOPICAL SOLUTION is normal and does not affect potency of the product.
Login To Your Free Account